A study of microplastics in U.S. coastal waters found that residents of counties adjacent to the most heavily microplastic-polluted waters had significantly higher rates of Type 2 diabetes, coronary artery disease (plaque-clogged blood vessels feeding the heart) and stroke compared to similar counties located near waters with low levels of microplastic pollution.

Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian partner the Medizinische Universität Wien, which aims to be the first device for monitoring cardiac function and early diagnosis of cardiac tamponade, a life-threatening complication after heart surgery. 

CRF announced the lineup of Late-Breaking Clinical Trials to be presented at New York Valves: The Structural Heart Summit taking place June 25-27, 2025, at the Jacob K. Javits Convention Center, North in New York, NY.

Researchers at Mass General Brigham, in collaboration with the U.S. Department of Veterans Affairs (VA), developed an AI tool called AI-CAC that analyzes routine chest CT scans to identify individuals at risk for cardiovascular events by detecting coronary artery calcium (CAC). The tool, shown to be highly accurate and predictive of 10-year mortality, could enable earlier intervention and help repurpose millions of existing CT scans for proactive heart disease prevention.